Literature DB >> 19188207

Estimates of measles case fatality ratios: a comprehensive review of community-based studies.

Lara J Wolfson1, Rebecca F Grais, Francisco J Luquero, Maureen E Birmingham, Peter M Strebel.   

Abstract

BACKGROUND: Global deaths from measles have decreased notably in past decades, due to both increases in immunization rates and decreases in measles case fatality ratios (CFRs). While some aspects of the reduction in measles mortality can be monitored through increases in immunization coverage, estimating the level of measles deaths (in absolute terms) is problematic, particularly since incidence-based methods of estimation rely on accurate measures of measles CFRs. These ratios vary widely by geographic and epidemiologic context and even within the same community from year-to-year.
METHODS: To understand better the variations in CFRs, we reviewed community-based studies published between 1980 and 2008 reporting age-specific measles CFRs.
RESULTS: The results of the search consistently document that measles CFRs are highest in unvaccinated children under age 5 years; in outbreaks; the lowest CFRs occur in vaccinated children regardless of setting. The broad range of case and death definitions, study populations and geography highlight the complexities in extrapolating results for global public health planning.
CONCLUSIONS: Values for measles CFRs remain imprecise, resulting in continued uncertainty about the actual toll measles exacts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188207     DOI: 10.1093/ije/dyn224

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  78 in total

Review 1.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

Review 2.  Antibiotics for preventing complications in children with measles.

Authors:  Sushil K Kabra; Rakesh Lodha
Journal:  Cochrane Database Syst Rev       Date:  2013-08-14

3.  Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.

Authors:  Hiten D Patel; Eric T Roberts; Dagna O Constenla
Journal:  Vaccine       Date:  2013-10-29       Impact factor: 3.641

4.  The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.

Authors:  David Bishai; Benjamin Johns; Divya Nair; Juliet Nabyonga-Orem; Braka Fiona-Makmot; Emily Simons; Alya Dabbagh
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

Review 5.  Zinc supplementation for the treatment of measles in children.

Authors:  Ajibola A Awotiwon; Olabisi Oduwole; Anju Sinha; Charles I Okwundu
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

6.  Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: A modeling application in Kenya.

Authors:  Bruce Y Lee; Shawn T Brown; Leila A Haidari; Samantha Clark; Taiwo Abimbola; Sarah E Pallas; Aaron S Wallace; Elizabeth A Mitgang; Jim Leonard; Sarah M Bartsch; Tatenda T Yemeke; Eli Zenkov; Sachiko Ozawa
Journal:  Vaccine       Date:  2019-03-25       Impact factor: 3.641

7.  Modelling the first dose of measles vaccination: the role of maternal immunity, demographic factors, and delivery systems.

Authors:  C J E Metcalf; P Klepac; M Ferrari; R F Grais; A Djibo; B T Grenfell
Journal:  Epidemiol Infect       Date:  2010-06-07       Impact factor: 2.451

8.  Reduced vaccination and the risk of measles and other childhood infections post-Ebola.

Authors:  Saki Takahashi; C Jessica E Metcalf; Matthew J Ferrari; William J Moss; Shaun A Truelove; Andrew J Tatem; Bryan T Grenfell; Justin Lessler
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

9.  Quantifying child mortality reductions related to measles vaccination.

Authors:  Jeremy D Goldhaber-Fiebert; Marc Lipsitch; Ajay Mahal; Alan M Zaslavsky; Joshua A Salomon
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

10.  Emergence and re-emergence of viral diseases of the central nervous system.

Authors:  Diane E Griffin
Journal:  Prog Neurobiol       Date:  2009-12-10       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.